150 related articles for article (PubMed ID: 20197411)
1. Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans.
Lesage S; Patin E; Condroyer C; Leutenegger AL; Lohmann E; Giladi N; Bar-Shira A; Belarbi S; Hecham N; Pollak P; Ouvrard-Hernandez AM; Bardien S; Carr J; Benhassine T; Tomiyama H; Pirkevi C; Hamadouche T; Cazeneuve C; Basak AN; Hattori N; Dürr A; Tazir M; Orr-Urtreger A; Quintana-Murci L; Brice A;
Hum Mol Genet; 2010 May; 19(10):1998-2004. PubMed ID: 20197411
[TBL] [Abstract][Full Text] [Related]
2. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
[TBL] [Abstract][Full Text] [Related]
3. Evidence for prehistoric origins of the G2019S mutation in the North African Berber population.
Ben El Haj R; Salmi A; Regragui W; Moussa A; Bouslam N; Tibar H; Benomar A; Yahyaoui M; Bouhouche A
PLoS One; 2017; 12(7):e0181335. PubMed ID: 28723952
[TBL] [Abstract][Full Text] [Related]
4. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
[TBL] [Abstract][Full Text] [Related]
5. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
[TBL] [Abstract][Full Text] [Related]
6. LRRK2 G2019S in the North African population: a review.
Benamer HT; de Silva R
Eur Neurol; 2010; 63(6):321-5. PubMed ID: 20413974
[TBL] [Abstract][Full Text] [Related]
7. The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.
Thaler A; Ash E; Gan-Or Z; Orr-Urtreger A; Giladi N
J Neural Transm (Vienna); 2009 Nov; 116(11):1473-82. PubMed ID: 19756366
[TBL] [Abstract][Full Text] [Related]
8. G2019S LRRK2 mutation in familial and sporadic Parkinson's disease in Russia.
Pchelina SN; Yakimovskii AF; Ivanova ON; Emelianov AK; Zakharchuk AH; Schwarzman AL
Mov Disord; 2006 Dec; 21(12):2234-6. PubMed ID: 17044089
[TBL] [Abstract][Full Text] [Related]
9. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.
Zabetian CP; Hutter CM; Yearout D; Lopez AN; Factor SA; Griffith A; Leis BC; Bird TD; Nutt JG; Higgins DS; Roberts JW; Kay DM; Edwards KL; Samii A; Payami H
Am J Hum Genet; 2006 Oct; 79(4):752-8. PubMed ID: 16960813
[TBL] [Abstract][Full Text] [Related]
10. Genetic analysis of LRRK2 mutations in patients with Parkinson disease.
Deng H; Le W; Guo Y; Hunter CB; Xie W; Huang M; Jankovic J
J Neurol Sci; 2006 Dec; 251(1-2):102-6. PubMed ID: 17097110
[TBL] [Abstract][Full Text] [Related]
11. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.
Lee AJ; Wang Y; Alcalay RN; Mejia-Santana H; Saunders-Pullman R; Bressman S; Corvol JC; Brice A; Lesage S; Mangone G; Tolosa E; Pont-Sunyer C; Vilas D; Schüle B; Kausar F; Foroud T; Berg D; Brockmann K; Goldwurm S; Siri C; Asselta R; Ruiz-Martinez J; Mondragón E; Marras C; Ghate T; Giladi N; Mirelman A; Marder K;
Mov Disord; 2017 Oct; 32(10):1432-1438. PubMed ID: 28639421
[TBL] [Abstract][Full Text] [Related]
12. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
Lesage S; Janin S; Lohmann E; Leutenegger AL; Leclere L; Viallet F; Pollak P; Durif F; Thobois S; Layet V; Vidailhet M; Agid Y; Dürr A; Brice A; ; Bonnet AM; Borg M; Broussolle E; Damier P; Destée A; Martinez M; Penet C; Rasco O; Tison F; Tranchan C; Vérin M
Arch Neurol; 2007 Mar; 64(3):425-30. PubMed ID: 17353388
[TBL] [Abstract][Full Text] [Related]
13. Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.
Bar-Shira A; Hutter CM; Giladi N; Zabetian CP; Orr-Urtreger A
Neurogenetics; 2009 Oct; 10(4):355-8. PubMed ID: 19283415
[TBL] [Abstract][Full Text] [Related]
14. The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel.
Hassin-Baer S; Laitman Y; Azizi E; Molchadski I; Galore-Haskel G; Barak F; Cohen OS; Friedman E
J Neurol; 2009 Mar; 256(3):483-7. PubMed ID: 19412725
[TBL] [Abstract][Full Text] [Related]
15. LRRK2 in Parkinson's disease: genetic and clinical studies from patients.
Kumari U; Tan EK
FEBS J; 2009 Nov; 276(22):6455-63. PubMed ID: 19804413
[TBL] [Abstract][Full Text] [Related]
16. LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.
Bardien S; Marsberg A; Keyser R; Lombard D; Lesage S; Brice A; Carr J
J Neural Transm (Vienna); 2010 Jul; 117(7):847-53. PubMed ID: 20544233
[TBL] [Abstract][Full Text] [Related]
17. Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease.
Squillaro T; Cambi F; Ciacci G; Rossi S; Ulivelli M; Malandrini A; Mencarelli MA; Mari F; Renieri A; Ariani F
J Hum Genet; 2007; 52(3):201-204. PubMed ID: 17235449
[TBL] [Abstract][Full Text] [Related]
18. Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.
Correia Guedes L; Ferreira JJ; Rosa MM; Coelho M; Bonifati V; Sampaio C
Parkinsonism Relat Disord; 2010 May; 16(4):237-42. PubMed ID: 19945904
[TBL] [Abstract][Full Text] [Related]
19. Absence of commonly reported leucine-rich repeat kinase 2 mutations in Eastern Indian Parkinson's disease patients.
Sanyal J; Sarkar B; Ojha S; Banerjee TK; Ray BC; Rao VR
Genet Test Mol Biomarkers; 2010 Oct; 14(5):691-4. PubMed ID: 20722494
[TBL] [Abstract][Full Text] [Related]
20. Genetic screening of the G2019S mutation of the LRRK2 gene in Southwest European, North African, and Sephardic Jewish subjects.
Change N; Mercier G; Lucotte G
Genet Test; 2008 Sep; 12(3):333-9. PubMed ID: 18666856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
